Boji Pharmaceutical Co., Ltd.
博济医药
300404
Shenzhen Stock Exchange
Key Financials
Announcements
Legal Opinion from Beijing Kangda (Guangzhou) Law Firm on the 2025 Annual Shareholders' Meeting of the Company
Announcement of Resolutions from the 2025 Annual Shareholders' Meeting
Announcement on the Repurchase and Cancellation of Some Restricted Stocks to Notify Creditors
Continuous Supervision Tracking Report for the Company's 2025 Annual Report by GF Securities Co., Ltd.
Summary Report on the Company's 2023 Issuance of Stocks to Specific Objects by GF Securities Co., Ltd.
2025 Annual Remuneration of Directors and Senior Management and the Remuneration Plan for 2026
Announcement on the Proposed Reappointment of the Accounting Firm
2025 Annual Independent Director Work Report (Li Huayi)
2025 Annual Independent Director Work Report (Chen Qing)
2025 Annual Independent Director Work Report (Xie Kang)
Announcement on Holding an Online Explanation Meeting for the Company's 2025 Annual Report
Guangfa Securities Co., Ltd. Verification Opinion on Boji Medical Technology Co., Ltd.'s 2025 Annual Internal Control Evaluation Report
Internal Control Audit Report
2025 Annual Internal Control Evaluation Report
Remuneration Management System for Directors and Senior Management (April 2026)
Announcement on Changes in Accounting Policies
Announcement on Provision for Asset Impairment Losses, Credit Impairment Losses, and Write-off of Assets
Announcement on the Company's Receipt of Drug Clinical Trial Approval Notice
Legal Opinion Letter from Beijing Kangda (Guangzhou) Law Firm on the Company's Repurchase and Cancellation of Certain Restricted Stocks
Review Opinion of the Compensation and Assessment Committee of the 5th Board of Directors on the Repurchase and Cancellation of Certain Restricted Stocks
Announcement on the Repurchase and Cancellation of Certain Restricted Stocks
Guangfa Securities Co., Ltd. Verification Opinion on the Confirmation of 2025 Routine Related Transactions and Estimated Routine Related Transactions for 2026 by Boji Medical Technology Co., Ltd.
Announcement on Confirming 2025 Routine Related Transactions and Estimated Routine Related Transactions for 2026
Announcement on Providing Financing Guarantees for Subsidiaries
Announcement on Providing Business Contract Guarantees for Subsidiaries
Announcement on Applying for Financing Credit Limits from Financial Institutions
Notice of the 2025 Annual Shareholders' Meeting
Resolution Announcement of the 20th Meeting of the 5th Board of Directors
Announcement on the Company's Profit Distribution Plan for 2025
Q1 2026 Report
Special Report on Fund Raising Storage, Management, and Usage for 2025
Annual Verification Report on Fund Raising Storage, Management, and Usage
Guangfa Securities Co., Ltd. Verification Opinion on the Company's 2025 Annual Fund Raising Storage, Management, and Usage
Report on the Evaluation of the Accounting Firm's Performance in 2025 and the Audit Committee's Supervision Responsibilities
Special Audit Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions
Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025
Special Report on the Board's Self-Examination of the Independence of Independent Directors
2025 Annual Audit Report
2025 Annual Report
Summary of the 2025 Annual Report
Announcement on Signing the 'Technology Transfer Contract'
Announcement on the Company Obtaining an Invention Patent Certificate
Announcement on changes related to the Daoyuan Angel Equity Investment Fund
Announcement on the Full-owned Subsidiary Obtaining the Drug Clinical Trial Approval Notice
Announcement on Results of Repurchased Share Reduction and Share Changes
Announcement on the First Repurchase of Shares
Resolutions Announcement of the Nineteenth Meeting of the Fifth Board of Directors
Announcement on Share Repurchase and Centralized Bidding Reduction Plan
Notes & Comments
Sign in to leave a comment or private note.
Loading…